Evolving Landscape of Glioblastoma Research: Integrating Therapeutic Advances and Diagnostic Frontiers
Brain Sciences · 30.04.2026 · 16 (5) · 487
DOI: 10.3390/brainsci16050487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 30.04.2026. Verfasst von Nirupama A Sabnis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Genetics, University of North Texas Health, Fort Worth, TX 76107, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wheels for wellness Foundation, Virginia M. Kinkaid Foundation.
Abstract (Originalsprache)
Glioblastoma (GB) remains the most aggressive primary brain malignancy, with the Stupp regimen persisting as the standard of care for nearly two decades despite poor survival outcomes. This review was synthesized by extensively reviewing and analyzing the literature from PubMed, Scopus, and Web of Science to evaluate the emerging promising therapeutic and diagnostic strategies for combating GB. Results indicate significant progress in molecularly targeted therapies, biomimetic nanocarriers, and advanced radiotherapy. While immunotherapeutic approaches, such as checkpoint inhibitors and vaccines, show variable clinical success, the integration of bioinformatics and machine learning has significantly enhanced treatment response prediction. Furthermore, advances in radiomics and molecular imaging have improved the differentiation between true tumor progression and pseudoprogression, potentially reducing invasive diagnostic requirements. Additionally, other emerging and investigational adjuvant therapeutic approaches have shown promise. We conclude that, while multimodal strategies integrating molecular and computational approaches offer a path toward personalized GB management, significant barriers—namely tumor heterogeneity and the blood–brain barrier—persist. Future research must prioritize precision-based combinatorial models to successfully translate these preclinical advancements into improved clinical outcomes for patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Genetics, University of North Texas Health, Fort Worth, TX 76107, USA.
- Biology Department, Uppsala University, 753 10 Uppsala, Sweden.
- Burnette School of Medicine, Texas Christian University, Fort Worth, TX 76109, USA.
- College of Science and Engineering, Texas Christian University, Fort Worth, TX 76109, USA.
- Department of Pharmacology and Neuroscience, University of North Texas Health, Fort Worth, TX 76107, USA.
- Systems Science, University of North Texas Health, Fort Worth, TX 76107, USA.
ORCID-Profile: Nirupama A Sabnis, Luke C Cooksey, Hareesh Jayakumar, Ezek Mathew, Amalendu Ranjan, Luis Colon-Perez, Porunelloor A Mathew, Bruce A Bunnell
Förderung
- Wheels for wellness Foundation
- Virginia M. Kinkaid Foundation
Zitieren
APA
Sabnis, N. A., Cooksey, L. C., Jayakumar, H., Moguel Mendez, M., Mathew, E., Petty, R. M., Ranjan, A., Colon-Perez, L., Dickerman, R., Mathew, P. A., & Bunnell, B. A. (2026). Evolving Landscape of Glioblastoma Research: Integrating Therapeutic Advances and Diagnostic Frontiers. Brain Sciences, 16(5), 487. https://doi.org/10.3390/brainsci16050487
Vancouver
Sabnis NA, Cooksey LC, Jayakumar H, Moguel Mendez M, Mathew E, Petty RM, et al. Evolving Landscape of Glioblastoma Research: Integrating Therapeutic Advances and Diagnostic Frontiers. Brain Sciences. 2026;16(5):487. doi:10.3390/brainsci16050487
BibTeX
@article{Sabnis2026,
author = {Sabnis, Nirupama A and Cooksey, Luke C and Jayakumar, Hareesh and Moguel Mendez, Mariana and Mathew, Ezek and Petty, Roland Max and Ranjan, Amalendu and Colon-Perez, Luis and Dickerman, Rob and Mathew, Porunelloor A and Bunnell, Bruce A},
title = {Evolving Landscape of Glioblastoma Research: Integrating Therapeutic Advances and Diagnostic Frontiers},
journal = {Brain Sciences},
year = {2026},
volume = {16},
number = {5},
pages = {487},
doi = {10.3390/brainsci16050487}
}
EUVIMED